Vaccination News Home Page                                            subscribe Vaccination NewsLetter

http://adc.bmjjournals.com/cgi/content/abstract/archdischild;88/3/222

ADC EBN Online
 

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Full Text of this Article
Reprint (PDF) Version of this Article
Email this link to a friend
eLetters: Submit a response to this article
Similar articles found in:
ADC Online
PubMed
PubMed Citation
This Article has been cited by:
other online articles
Search Medline for articles by:
Miller, E || Taylor, B
Alert me when:
new articles cite this article
 
Download to Citation Manager
Collections under which this article appears:
Drugs: immunological products and vaccines
Children

Archives of Disease in Childhood 2003;88:222-223
© 2003 BMJ Publishing Group & Royal College of Paediatrics and Child Health

 


SHORT REPORT

Bacterial infections, immune overload, and MMR vaccine

E Miller1, N Andrews2, P Waight1 and B Taylor3

1 Immunisation Division, Communicable Disease Surveillance Centre, Public Health Laboratory Service, 61 Colindale Avenue, London NW9 5EQ, UK
2 Statistics Unit, Public Health Laboratory Service
3 Centre for Community Child Health, Royal Free and University College Medical School, Royal Free Campus, University College London, London NW3 2PF, UK

 

Correspondence to:
Dr E Miller, Immunisation Division, Communicable Disease Surveillance Centre, Public Health Laboratory Service, 61 Colindale Avenue, London NW9 5EQ, UK;
emiller@phls.org.uk


ABSTRACT
Combined measles, mumps, and rubella (MMR) vaccine did not increase the risk of hospitalisation with invasive bacterial infection in the three months after vaccination; rather there was a protective effect. These results provide no support for the concept of "immunological overload" induced by multiple antigen vaccinations, nor calls for single antigen vaccines.

 


Keywords: MMR vaccine; vaccine safety; immune interference; immune overload

 

Abbreviations: MMR, measles, mumps, and rubella; RI, relative incidence


This article has been cited by other articles:

 


 
Home page
 
BMJHome page
Minerva
BMJ, March 8, 2003; 326(7388): 558 - 558.
[Full Text] [PDF]




 

 


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

 

Vaccination News Home Page

ALL INFORMATION, DATA, AND MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR LEGAL ADVICE.  THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH YOUR HEALTH CARE PROVIDER.